Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

J. Ostroff



Author of

  • +

    MTE 31 - Smoking Cessation Integrated with Screening (Window of Opportunity) (Ticketed Session) (ID 83)

    • Event: WCLC 2015
    • Type: Meet the Expert (Ticketed Session)
    • Track: Prevention and Tobacco Control
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/09/2015, 07:00 - 08:00, 708+710+712
    • +

      MTE31.02 - Smoking Cessation Integrated with Screening (Window of Opportunity) (ID 2021)

      07:30 - 08:00  |  Author(s): J. Ostroff

      • Abstract
      • Presentation

      Abstract:
      Lung cancer screening with computed tomography has demonstrated a significant reduction in mortality (1) leading to the recommendation for annual low-dose CT (LDCT) screening for lung cancer for adults between 55 and 80 years old who are at high risk for lung cancer because of their age and extensive smoking history. In addition to lung cancer screening having public health benefit for early detection of lung cancer, lung cancer screening programs may also represent a “teachable moment” for reaching smokers and promoting cessation through the delivery of evidence-based tobacco cessation treatment (2). Since the advent of lung cancer screening programs, there has been much interest in the impact of lung cancer screening on smoking behaviors. Ostroff and colleagues (3) first published the observation that 25% of current smokers seeking lung cancer screening reported smoking cessation one-year following enrollment in a lung cancer screening program Since then, several observational studies have reported cessation rates ranging from 6.6% to 42% following enrollment in lung cancer screening programs (4-11). However, a more recent systematic review of clinical trials and cohort studies examining smoking behaviors among individuals undergoing LDCT for lung cancer screening concluded that lung cancer screening per se does not change smoking behaviors leading to the conclusion that further research is needed to develop and evaluate cost-effective models for delivery of tobacco treatment in lung cancer screening protocols (12). A recent survey of lung cancer screening sites examined the organizational priority, practice patterns and perceived barriers associated with tobacco treatment (13). To facilitate the integration of tobacco treatment within lung cancer screening programs, a greater understanding of the barriers associated with implementation is needed. Thus, the presentation objectives are to: 1) Establish the rationale for integration of tobacco dependence treatment in lung cancer screening programs; 2) Examine patterns and predictors of smoking cessation among lung cancer screening program enrollees; 3) Examine current organizational priority, practice patterns and perceived barriers associated with tobacco treatment delivery; 4) Review opportunities and challenges of integrating tobacco dependence in lung cancer screening protocols. This presentation will provide a blueprint for developing and implementing evidence-based tobacco treatment services within the context of lung cancer screening program. 1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England journal of medicine. 2011;365(5):395-409. Epub 2011/07/01. PMID: 21714641. 2. Poghosyan H, Kennedy Sheldon L, Cooley ME. The impact of computed tomography screening for lung cancer on smoking behaviors: a teachable moment? Cancer nursing. 2012;35(6):446-75. Epub 2012/01/03. PMID: 22209869. 3. Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Preventive medicine. 2001;33(6):613-21. Epub 2001/11/22. PMID: 11716658. 4. Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax. 2009;64(5):388-92. Epub 2008/12/05. PMID: 19052048. 5. Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung cancer (Amsterdam, Netherlands). 2004;44(1):13-21. Epub 2004/03/12. PMID: 15013579. 6. Cox LS, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Change in smoking status after spiral chest computed tomography scan screening. Cancer. 2003;98(11):2495-501. Epub 2003/11/25. PMID: 14635086. 7. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006;61(1):54-6. Epub 2006/01/07. PMCID: PMCPMC2080704. 8. Schnoll RA, Miller SM, Unger M, McAleer C, Halbherr T, Bradley P. Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development. Lung cancer (Amsterdam, Netherlands). 2002;37(3):257-65. Epub 2002/09/18. PMID: 12234693. 9. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung cancer (Amsterdam, Netherlands). 2007;56(1):125-34. Epub 2007/01/02. PMID: 17196298. 10. Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005;103(10):2154-62. Epub 2005/04/13. PMID: 15825210. 11. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010;65(7):600-5. Epub 2010/07/16. PMID: 20627916. 12. Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. Preventive Services Task Force. Annals of the American Thoracic Society. 2014;11(4):619-27. Epub 2014/04/08. PMID: 24701999. 13. Ostroff J, Borderud S, Copeland A, editors. Readiness and capacity of US lung cancer screening sites to deliver tobacco dependence treatment. Healthography: American Public Health Association 142nd Annual Meeting & Expo; 2014; New Orleans, LA.

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

  • +

    ORAL 08 - Smoking Cessation, Tobacco Control and Lung Cancer (ID 94)

    • Event: WCLC 2015
    • Type: Oral Session
    • Track: Prevention and Tobacco Control
    • Presentations: 1
    • +

      ORAL08.04 - Discussant for ORAL08.01, ORAL08.02, ORAL08.03 (ID 3316)

      11:18 - 11:28  |  Author(s): J. Ostroff

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.